Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2019/01/02
-
Journal
-
Indian UGC (journal)
-
Refrences68
-
Citations65
-
Amrish Jain
-
Rossana Baracco
-
Gaurav Kapur
Cite
Jain, Amrish, et al. “Pheochromocytoma and paraganglioma—an Update on Diagnosis, Evaluation, and Management”. Pediatric Nephrology, vol. 35, no. 4, 2019, pp. 581-94, https://doi.org/10.1007/s00467-018-4181-2.
Jain, A., Baracco, R., & Kapur, G. (2019). Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management. Pediatric Nephrology, 35(4), 581-594. https://doi.org/10.1007/s00467-018-4181-2
Jain A, Baracco R, Kapur G. Pheochromocytoma and paraganglioma—an update on diagnosis, evaluation, and management. Pediatric Nephrology. 2019;35(4):581-94.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the genitourinary system
Urology
Medicine
Medicine (General)
Medicine
Pediatrics
You May Also Like
- Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease
- Prevalence of chronic kidney disease in the Japanese general population
- Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides
- Aborted sudden cardiac death in two patients with Bartter’s/Gitelman’s syndromes
- Shortage of healthcare workers in sub-Saharan Africa: a nephrological perspective
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Pharmacology of Combined ??-??-Blockade II Haemodynamic Effects of Labetalol | Drugs |
| 46 | 1984 |
| 10.1007/s00441-018-2791-4 | Cell and Tissue Research |
| 2018 | |
Pathology and genetics of phaeochromocytoma and paraganglioma | Histopathology |
| 98 | 2018 |
| Metanephrines for Evaluating Palpitations and Flushing | JAMA |
| 7 | 2017 |
| Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1 | Clinical Endocrinology |
| 64 | 2017 |
Refrences Analysis
The category
Medicine: Medicine (General) 37
is the most frequently represented among the references in this article. It primarily includes studies from Clinical Endocrinology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A previously healthy 3-year-old female with hypertension, proteinuria, and hypercalciuria | Pediatric Nephrology |
| 2024 | |
| A Woman with Bilateral Pheochromocytoma and Tuberous Sclerosis Complex | AACE Clinical Case Reports |
| 1 | 2024 |
| Aggressive posterior paraganglioma presenting with generalized weakness, anemia, hypertension, and weight loss: A case report | Urology Case Reports | 2024 | ||
| Ectopic adrenocorticotropic hormone-secreting pheochromocytoma with severe metabolic disturbances: A case report | International Journal of Surgery Case Reports |
| 2024 | |
Clinical diagnosis of pheochromocytoma and paraganglioma‐induced secondary hypertension through UPLC‐MS/MS analysis of plasma catecholamines and their metabolites | The Journal of Clinical Hypertension |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 36
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled The Identification of Differentially Expressed Genes Showing Aberrant Methylation Patterns in Pheochromocytoma by Integrated Bioinformatics Analysis and was published in 2019. The most recent citation comes from a 2024 study titled Management of Abdominal Paraganglioma: A Single Center’s Experience. This article reached its peak citation in 2022, with 21 citations. It has been cited in 57 different journals, 35% of which are open access. Among related journals, the Frontiers in Endocrinology cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.